MedPath

Vegan Diet in Small Children

Recruiting
Conditions
Vegan Diet
Registration Number
NCT05442281
Lead Sponsor
Umeå University
Brief Summary

Following increased knowledge about climate change and how food production affects greenhouse gas emissions, the interest in vegetarian diets is increasing. In line with this, also vegan diet is becoming more common at all ages, including in young children. But the state of knowledge regarding the effect of this diet on children during infancy and early childhood has been poorly studied and existing literature consists to a large extent of case reports.

With the main hypothesis that vegan diet from the introduction of complementary foods causes reduced bio availability of certain micronutrients important for development, the aim of this study is to examine dietary intake and development during the first years of life in a group of children eating vegan diet and compare with a reference group eating mixed diets.

In an observational study, investigators plan to include 30 children before the age of 6 months during the years 2021-2026, where the parents have decided to offer their child only vegan food. The children are studied in comparison with a reference group of 30 matched cases regarding growth, nutritional status, and dietary intake. Data collection includes monthly dietary records and blood sample analyses and growth at 6, 12 and 24 months. At the age of 3, cognitive developmental assessment (WPSSI-IV) and an DEXA examination of body composition are performed.

The study is expected to contribute to increased knowledge about the risk and benefits of vegan diets and thereby provide a better basis for future recommendations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Planned exclusive vegan diet or mixed diet respectively from 6 months of age until at least 2 years of life
  • Exclusively (>90%) breastfed until 4 months
  • Born term (GE 37+0 - 41+6)
  • Single birth
  • Birth weight >2500 g
  • Apgar score 5 min > 5
Exclusion Criteria

* A chronic disease affecting growth or neurodevelopment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concentration of Hemoglobin12 months of age

Blood

Body Weight (kg)12 months of age

measured weight at 12 mo using a device for measuring weight

Secondary Outcome Measures
NameTimeMethod
Zink level6, 12, 24, 36 months

Serum sample

D-vitamin levels6, 12, 24, 36 months

Serum sample

Fat mass index3 years of age

FMI, measured by DEXA-scan

Transferrin saturation12 months of age

serum sample

Wechsler Preschool & Primary Scale of Intelligence3 years of age

Scale for cognitive development. Expected mean 100. Higher scores equals better cognitive development.

Protein intakeat 12 months of age

3 day food diary

B12 levels6, 12, 24, 36 months

Serum sample

Calcium levels6, 12, 24, 36 months

Serum sample

Homocysteine levels6, 12, 24, 36 months

serum sample

Circumference of the head12 months of age

measured at 12 mo using measuring tool for children

Lean mass index3 years of age

LMI, measured by DEXA-scan

Fat intakeat 12 months of age

3 day food diary

Iron intake (mg/day)throughout study

3 day food diary

Transferrin receptor concentration12 months of age

Serum sample

Length of body12 months of age

measured length at 12 mo using measuring tool for children

Carbohydrate intakeat 12 months of age

3 day food diary

Mean cell volume12 months of age

Blood sample

Ferritin12 months of age

Serum sample

Trial Locations

Locations (1)

Umeå University, Department of Clinical Sciences

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath